In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Ocular Therapeutix Inc’s stock clocked out at $11.14, up 2.30% from its previous closing price of $10.89. In other words, the price has increased by $2.30 from its previous closing price. On the day, 0.72 million shares were traded. OCUL stock price reached its highest trading level at $11.25 during the session, while it also had its lowest trading level at $10.93.
Ratios:
To gain a deeper understanding of OCUL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 16.55 and its Current Ratio is at 16.64. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.19.
On June 20, 2024, TD Cowen Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $7 to $11.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 16 ’24 when PHILIP C. STRASSBURGER bought 13,125 shares for $10.23 per share.
Nayak Sanjay sold 1,832 shares of OCUL for $16,525 on Aug 23 ’24. The Chief Strategy Officer now owns 176,194 shares after completing the transaction at $9.02 per share. On Aug 23 ’24, another insider, Dugel Pravin, who serves as the insider of the company, sold 20,880 shares for $9.02 each. As a result, the insider received 188,338 and left with 812,473 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCUL now has a Market Capitalization of 1736971136 and an Enterprise Value of 1352165632. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.43 while its Price-to-Book (P/B) ratio in mrq is 4.59. Its current Enterprise Value per Revenue stands at 22.131 whereas that against EBITDA is -12.21.
Stock Price History:
Over the past 52 weeks, OCUL has reached a high of $11.60, while it has fallen to a 52-week low of $2.00. The 50-Day Moving Average of the stock is 19.69%, while the 200-Day Moving Average is calculated to be 47.38%.
Shares Statistics:
It appears that OCUL traded 1.16M shares on average per day over the past three months and 1301890 shares per day over the past ten days. A total of 155.92M shares are outstanding, with a floating share count of 134.99M. Insiders hold about 13.42% of the company’s shares, while institutions hold 78.72% stake in the company. Shares short for OCUL as of 1728950400 were 13263085 with a Short Ratio of 11.48, compared to 1726185600 on 17456243. Therefore, it implies a Short% of Shares Outstanding of 13263085 and a Short% of Float of 8.540000000000001.
